Ottawa, ON – MDS Nordion, a developer of medical isotopes and radiopharmaceuticals used in molecular imaging, says it is collaborating with the University of Ottawa Heart Institute to establish a Molecular Imaging Centre of Excellence to advance cardiology research.
MDS Nordion will invest an estimated US $2.2 million in the new centre, which will be equipped with a research and development radiochemistry laboratory to support cardiology research.
Scheduled to open later this year on the institute’s campus, the new centre will enable the two organizations to collaborate on joint cardiology research using the latest in molecular imaging technology. Through this collaboration, MDS Nordion will also provide its innovative molecular imaging services to large pharmaceutical companies.
“We are making a major commitment to innovation with this new centre that can ultimately make a profound difference in the lives of cardiac patients,” said Steve West, president of MDS Nordion. “By joining forces with the University of Ottawa Heart Institute, we have a phenomenal opportunity to share world-class knowledge, equipment and advanced technology to improve cardiac care.”
“This collaboration will enable the Heart Institute to remain at the forefront of cardiovascular care, education and research,” says Dr Terrence Ruddy, chief of cardiology, University of Ottawa Heart Institute. “The centre is an important addition that will add a new dimension to our research infrastructure.”